08:30

Gathering & Registration

 

09:00

Greetings

Prof. Joseph Klafter, President, TAU

Prof. Yoav Henis, Vice President, TAU

Prof. Ehud Gazit, Head, BLAVATNIK CENTER for Drug Discovery

Prof. Inna Slutsky, Sagol School of Neuroscience

09:40-10:20

KeyNote Session

Chair: Prof. Inna Slutsky, TAU

Prof. Søren W. Gersting, Pediatric Research at Kinder-UKE, University Medical Center Hamburg Eppendorf
Pharmacological chaperones for the treatment of rare diseases; The Kinder-UKE screening platform

10:20-11:20

Session 1

Chair: Dr. Moran Rubinstein, TAU

Dr. Ilan Dienstein, Ben Gurion University
From sleep recordings to motion capture: developing objective quantitative measures of symptom severity in children with autism

Prof. Hanoch Senderowitz, Bar Ilan University
Combating Cystic Fibrosis: Computational Studies on CFTR

Dr. Evan Elliot, Bar Ilan University
Microbiome-Epigenetic-Genetic interaction in the development of autism spectrum disorder

11:20-11:40

Coffee Break

 

11:40-13:00

Session 2

Chair: Dr. Lior Mayo, TAU

Prof. Dani Offen, Rabin Medical Center-Beilinson Campus
Stem Cells in the Treatment of Autism

Dr. Boaz Barak, TAU
Altered myelination as a novel pathophysiological approach in Williams syndrome

Dr. Yair Anikster, Sheba Medical Center
Novel metabolic pathways: Paving the path towards targeted treatment

Shiri Sudri, MD Rambam Health Care Campus
Visual loss in children: In with the new

13:00-14:00

Lunch Break

 

14:00-14:30

KeyNote Session

Chair: Dr. Omri Wurtzel, TAU

Dr. Alessandro Prigione, Max-Delbrück-Centrum for Molecular Medicine

Modeling and drug discovery of Leigh syndrome using patient-derived neural cells


14:30-15:45

Session 3

Chair: Prof. Ditza Antebi-Zachor, TAU and Assaf Harofe Medical Center

Dr. Gali Havazelet-Heimer, Sheba Medical Center
Angelman syndrome – from the clinic to the search for novel therapeutic strategies

Prof. Illana Gozes, TAU
Activity-dependent neuroprotective protein (ADNP) deficiency models synaptic and developmental phenotypes of autism-like syndrome: Toward innovative drug development

Prof. David (Dedi) Meiri, Technion
Behind the smokescreen of medical cannabis

Dr. Tzipi Horowitz-Kraus, Technion

Neuroplasticity in developmental disorders: the specific case of dyslexia

15:45-16:00

Coffee Break

 

16:00-17:00

Expert Panel

Panel Host: Prof. Ehud Gazit, TAU

Opening Panel Lecture: Prof. Lilach Shalev-Mevorach, TAU

Personalized attention and cognitive control training for children with Autism: A potential booster for everyday functioning

Panel Members

Prof. Manuel Trajtenberg, TAU

Prof. Lilach Shalev-Mevorach, TAU

Mr. Amos Shapira, ALUT

Dr. Yael Gruenbaum-Cohen, Medison Ventures

17:00-18:00

Round table and networking cocktail event


Speakers